Concept Medical Inc. is proud to announce the successful enrollment of the first patients in the STARS DAPT randomized ...

A new study published in the journal of PloS One showed that although reoperative therapy with evolocumab with rosuvastatin ...

Longer times from symptom onset to randomization equaled a smaller—or perhaps no—advantage for Impella vs standard care.

Door-to-balloon times were no higher than when cath lab staff donned traditional lead aprons in this single-center experience ...

Please provide your email address to receive an email when new articles are posted on . Long-term follow-up from DANAMI-3-PRIMULTI shows reduction in events after complete revascularization vs.

A new study finds that patients who suffer a STEMI heart attack while hospitalized are 10 times more likely to die than patients who suffer a STEMI outside the hospital. If you suffer a heart attack ...

It's best to have patients on aggressive lipid-lowering therapy before discharge after an acute ST-segment elevation myocardial infarction (STEMI), so why not start it right away — even in the cath ...

Operators safely shaved a few minutes off heart attack reperfusion times by taking patients straight to culprit lesion percutaneous coronary intervention (PCI) when they arrived at the catheterization ...

Lead augmented vector right (aVR) is a useful measure in the diagnosis of ST-segment elevation acute myocardial infarction (STEMI), indicates a new analysis of data from the HERO-2 trial. “Lead aVR is ...

A 50-year-old man comes to your emergency department at 11:00 PM to visit his mother, a patient in your care. Suddenly he develops substernal chest pressure radiating bilaterally across his chest. He ...